| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | HTR1E |
| Uniprot No | P28566 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 206-276aa |
| 氨基酸序列 | YHAAKSLYQKRGSSRHLSNRSTDSQNSFASCKLTQTFCVSDFSTSDPTTEFEKFHASIRIPPFDNDLDHPG |
| 分子量 | 33.55 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人HTR1E蛋白的3篇参考文献及其摘要概括：
1. **文献名称**：*Expression and characterization of the human 5-HT1E receptor in mammalian cells*
**作者**：Leff P., et al.
**摘要**：该研究报道了通过基因克隆技术在哺乳动物细胞(HEK293)中重组表达人源HTR1E受体，并利用放射性配体结合实验分析其药理特性。结果证实HTR1E对5-HT(5-羟色胺)具有高亲和力，并揭示了其与下游G蛋白信号通路的偶联机制。
2. **文献名称**：*Structural insights into the ligand recognition and signaling of human HTR1E receptor*
**作者**：Zhang Y., et al.
**摘要**：通过冷冻电镜技术解析了重组人HTR1E蛋白与其天然激动剂5-HT结合的复合物三维结构，揭示了配体结合口袋的关键氨基酸残基及受体激活的构象变化，为靶向HTR1E的药物设计提供结构基础。
3. **文献名称**：*Functional selectivity of synthetic agonists at the human HTR1E receptor*
**作者**：Kimura T., et al.
**摘要**：研究评估了多种合成化合物对重组HTR1E受体的激活效应，发现部分配体表现出偏向性信号(偏向cAMP抑制而非β-arrestin招募)，提示HTR1E的功能多样性可能为神经精神疾病治疗提供新策略。
(注：以上文献名为虚构，但内容基于该领域典型研究方向归纳，实际文献需通过学术数据库检索确认。)
The human HTR1E protein, encoded by the HTR1E gene, is a serotonin receptor belonging to the G protein-coupled receptor (GPCR) family. It specifically binds serotonin (5-hydroxytryptamine, 5-HT), a neurotransmitter critical for regulating mood, cognition, and sensory processing. As a member of the 5-HT1 receptor subfamily, HTR1E is distinguished by its unique pharmacological profile, exhibiting low affinity for selective ligands like triptans and atypical antipsychotics. Predominantly expressed in the cerebral cortex, hippocampus, and amygdala, it modulates neurotransmitter release and neuronal signaling through Gi/o protein coupling, leading to inhibition of adenylate cyclase and reduced cAMP production. Despite its discovery over three decades ago, HTR1E remains less characterized compared to other serotonin receptors, partly due to challenges in developing selective agonists/antagonists. Recombinant HTR1E protein, typically produced via heterologous expression systems (e.g., mammalian or insect cells), enables structural and functional studies. Its applications span drug discovery for neurological disorders (e.g., anxiety, depression, migraines) and elucidating receptor dimerization, signal transduction, and pathological roles in neuropsychiatric conditions. Recent advances in cryo-EM and computational modeling have further highlighted its therapeutic potential as a novel drug target.
×
